About Inspyr Therapeutics Inc.
Inspyr Therapeutics Inc. is a Pharmaceuticals company, headquartered in San Antonio, with 2 - 10 employees and annual revenue of $1M - $5M.
Inspyr Therapeutics, Inc., formerly GenSpera, Inc., is an integrated biopharmaceutical company. The Company is focused on the development of therapies to treat cancer, inflammation, and other diseases. It operates a technology platform based on adenosine chemistry and biology. Its product pipeline i...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Inspyr Therapeutics Inc. Company Highlights
Phone Number
(210) 479-xxxx
Corporate Office Address
2511 N Loop 1604 W Suite 204
San Antonio, 78258
Website
Inspyr Therapeutics Inc.'s Tech Stack
Frequently Asked Questions About
Inspyr Therapeutics Inc.
Log in or sign up to get full contact details and additional support.
What technologies does Inspyr Therapeutics Inc. use?
Inspyr Therapeutics Inc. uses technologies including Google Cloud, Lua, and Modernizr.
How do I contact Inspyr Therapeutics Inc.?
To contact Inspyr Therapeutics Inc., visit inspyrtx.com.
What companies are similar to Inspyr Therapeutics Inc.?
Companies similar to Inspyr Therapeutics Inc. include PharmaLogic Holdings Corp., Agani Ltd., and Advarra Consulting.
Where is Inspyr Therapeutics Inc. headquartered?
Inspyr Therapeutics Inc. is headquartered at 2511 N Loop 1604 W Suite 204, San Antonio.
What is the main phone number for Inspyr Therapeutics Inc.?
The main phone number for Inspyr Therapeutics Inc. is (210) 479-xxxx.
What is the official website for Inspyr Therapeutics Inc.?
The official website for Inspyr Therapeutics Inc. is inspyrtx.com.
What is the annual revenue of Inspyr Therapeutics Inc.?
The annual revenue of Inspyr Therapeutics Inc. is $1M - $5M.
How many employees does Inspyr Therapeutics Inc. have?
Inspyr Therapeutics Inc. has 2 - 10 employees.
What industry is Inspyr Therapeutics Inc. in?
Inspyr Therapeutics Inc. is in the Pharmaceuticals industry.
Last updated: June 19, 2025